Browse our Factor VII Proteins (F7)

Full name:
Coagulation Factor VII Proteins (F7)
On are 31 Coagulation Factor VII (F7) Proteins from 9 different suppliers available. Additionally we are shipping Factor VII Antibodies (213) and Factor VII Kits (60) and many more products for this protein. A total of 315 Factor VII products are currently listed.
AI132620, Cf7, F7, FVII, LOC100223776, mfVII, SPCA, wu:fb59f04, zgc:109870
list all proteins Gene Name GeneID UniProt
F7 14068 P70375
F7 2155 P08709
F7 260320 Q8K3U6

Show all synonyms

Factor VII Proteins (F7) by Origin

Select your origin of interest

Top referenced Factor VII Proteins

  1. Human Factor VII Protein expressed in Human Cells - ABIN2004310 : Li, Wang, Long, Su, Bukhory, Dai, Jin, Huang, Jia, Li, Fan, Liu, Wang: Novel antibody against a glutamic acid-rich human fibrinogen-like protein 2-derived peptide near Ser91 inhibits hfgl2 prothrombinase activity. in PLoS ONE 2014 (PubMed)

More Proteins for Factor VII Interaction Partners

Zebrafish Coagulation Factor VII (F7) interaction partners

  1. Hepsin (show HPN Proteins) plays a physiologically important role in factor VII (show TH Proteins) activation and hemostasis in zebrafish.

Rhesus Monkey Coagulation Factor VII (F7) interaction partners

  1. study reports the full-length cDNA sequences of rhesus monkey FVII; deduced protein sequence of FVII indicates the functional domains; comparison of three-dimensional protein structure with human shows high conservation between them

Mouse (Murine) Coagulation Factor VII (F7) interaction partners

  1. FVIIa binding to EPCR (show PROCR Proteins) leads to a barrier protective effect in vivo

  2. FVIIa binding to EPCR (show PROCR Proteins) on the endothelium facilitates the transport of FVIIa from circulation to extravascular tissues where TF resides

  3. Murine FVIIa binds poorly to murine EPCR (show PROCR Proteins).

  4. Conclude that the fVII-targeted verteporfin photodynamic therapy that we report here is a novel and effective therapeutic with improved selectivity for the treatment of breast cancer.

  5. The participation of Egr-1 (show EGR1 Proteins) in FVIIa-mediated regulation of keratinocyte function was confirmed by use of Egr-1 (show EGR1 Proteins)-deficient mice, wherein a significant delay in skin wound healing after injury was observed, relative to WT mice.

  6. Recombinant FVIIa readily associates with the vascular endothelium and subsequently enters into extravascular spaces where it is likely to bind to tissue factor (show F3 Proteins) and is retained for extended time periods.

  7. Gene targeting of tissue factor (show F3 Proteins), factor X, and factor VII (show TH Proteins) in mice: their involvement in embryonic development

  8. true circadian rhythms for FVII were found

  9. Data suggest that long-term expression of murine activated factor VII (show TH Proteins) is safe, but elevated levels cause premature mortality.

  10. tissue factor (show F3 Proteins)/Factor VIIa/PAR2 (show F2RL1 Proteins) signaling mediates neutrophil activation and fetal death in antiphospholipid syndrome and that statins may be a good treatment for women with aPL (show FASL Proteins)-induced pregnancy complications.

Human Coagulation Factor VII (F7) interaction partners

  1. heterozygotes for FVII deficiency show rare bleeding manifestations which are also present in the unaffected family members with normal FVII levels. This indicates that Factor VII (show TH Proteins) activity levels played no role in the occurrence of the bleeding symptoms. Furthermore, FVII levels of around 0.40 IU/dl are capable of assuring a normal hemostasis.

  2. Family-based association study revealed that the G allele of Protein Z (show PROZ Proteins) rs2273971, and haplotypes GA, CG, and CGA (show CGA Proteins) of Protein Z (show PROZ Proteins) and factor VII (show TH Proteins) had a significant effect on cerebral hemorrhage susceptibility.

  3. Circulating FVII, FVIIa and TFPI (show TFPI Proteins) were significantly elevated in women with severe preeclampsia in the absence of comparable changes in plasma TF levels.

  4. Our study findings suggest a link between FVII and AR in prostate cancer pathogenesis.

  5. Large deletions play a minor but essential role in the mutational spectrum of the F7 and F10 (show F10 Proteins) genes. Copy number analyses (e. g. MLPA) should be considered if sequencing cannot clarify the underlying reason of an observed coagulopathy. Of note, in cases of combined FVII/FX deficiency, a deletion of the two contiguous genes might be part of a larger chromosomal rearrangement.

  6. Structure-Function Relationship of the Interaction between Tissue Factor (show F3 Proteins) and Factor VIIa.

  7. Data suggest that allosteric regulation of FVIIa activity by tissue factor/thromboplastin (show F3 Proteins) binding appear to involve direct interaction with FVIIa active site, stabilizing segment 215-217, activating loop 3, and leading to enhanced FVIIa activity.

  8. The aim of the study was to evaluate the molecular basis behind low levels of FVII activity (FVII:C) levels in a cohort of Brazilian patients.

  9. The story of FVII well summarizes the efforts of both theoretical and clinical approaches in the characterization of a coagulation disorder, that is, among the rare bleeding conditions, most frequently encountered in clinical practice.

  10. Identified are the FVII gene mutations in the Chinese Han population of four unrelated FVII-deficient patients, and the effect of these mutations on the function of FVII molecule level has also been elucidated.

Rabbit Coagulation Factor VII (F7) interaction partners

Factor VII (F7) Protein Profile

Protein Summary

This gene encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond. In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa. Defects in this gene can cause coagulopathy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.

Alternative names and synonyms associated with Factor VII (F7)

  • coagulation factor VII (F7)
  • coagulation factor VII (f7)
  • coagulation factor VII (serum prothrombin conversion accelerator) (F7)
  • coagulation factor VII (CpipJ_CPIJ009142)
  • coagulation factor VII (CpipJ_CPIJ010295)
  • coagulation factor VII (CpipJ_CPIJ020127)
  • coagulation factor VII (LOC100223776)
  • coagulation factor VII (fa7)
  • AI132620 protein
  • Cf7 protein
  • F7 protein
  • FVII protein
  • LOC100223776 protein
  • mfVII protein
  • SPCA protein
  • wu:fb59f04 protein
  • zgc:109870 protein

Protein level used designations for Coagulation Factor VII Proteins (F7)

coagulation factor VII , clotting factor , serum prothrombin conversion accelerator , FVII coagulation protein , eptacog alfa , proconvertin

100137442 Papio anubis
114423 Danio rerio
721933 Macaca mulatta
6041558 Culex quinquefasciatus
6042636 Culex quinquefasciatus
6054487 Culex quinquefasciatus
100223776 Taeniopygia guttata
100528477 Ictalurus punctatus
14068 Mus musculus
2155 Homo sapiens
260320 Rattus norvegicus
100009399 Oryctolagus cuniculus
100727155 Cavia porcellus
733661 Sus scrofa
617960 Bos taurus
607661 Canis lupus familiaris
395086 Gallus gallus
101118369 Ovis aries
100987335 Pan paniscus
744785 Pan troglodytes
Selected quality suppliers for Factor VII Proteins (F7)
Did you look for something else?